. . . . . . . . . "\"Quinapril tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Quinapril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer quinapril tablets are within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see WARNINGS PRECAUTIONS Do not co-administer quinapril tablets with aliskiren in patients with diabetes\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "UpUNf2yvJuSsdaFE1M8gioPMwe/QVM7yV8D+C4u1wpHK+W/mhecxlvMqwN9bEc6j0QfIsy5C1I7AdSdqp77TdwnN/4Foa14nHXSueKuBgUdvMKBmobJkeKnZh6kJyca0LFcUgqVtPwePsZY9UQgRFniLNmmEUe/dGkD0TBDmiQw=" . . "2021-08-23T12:17:22.500+02:00"^^ . . . . .